Nanjing (1)

Locally Advanced Esophageal Carcinoma (1)

Recruiting (1)

phase 2 (1)

Jiangsu Cancer Institute & Hospital (1)

neoadjuvant chemotherapy (1)

neoadjuvant toripalimab (1)

short course neoadjuvant radiotherapy (1)

drug (1)

radiation (1)

Other (1)

Interventional (1)

locally advanced esophageal carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Nanjing, Jiangsu, China

Jiangsu Cancer Hospital /Jiangsu Institute of Cancer Research

Jun 21, 2022